Moreover, patients feature phenotypes, including hearing loss, intrauterine growth restriction, and short stature, that cannot be delineated to variations in the BCL11A gene but are associated with USP34 (ubiquitin specific peptidase 34) and XPO1 (exportin 1), two candidate genes in close proximity [47]. Here, XPO1 is linked to fetal growth restriction.